39
Participants
Start Date
September 1, 2024
Primary Completion Date
September 1, 2029
Study Completion Date
December 1, 2029
Pucotenlimab
Pucotenlimab is administered at 200mg, q3w，intravenous infusion
Carboplatin
AUC=4-6，q3w，intravenous infusion
Paclitaxel
175 mg/m2，q3w，intravenous infusion, administered over 30min.
Surgery
Transabdominal hysterectomy + bilateral adnexectomy + pelvic lymph node dissection + pelvic-abdominal tumor resection +/- para-abdominal aortic lymph node dissection
Women's hospital school of medicine zhejiang university, Hangzhou
Xiangya Hospital of Central South University
OTHER
Tongji Hospital
OTHER
Qilu Hospital of Shandong University
OTHER
Anhui Provincial Cancer Hospital
OTHER
Sichuan Cancer Hospital and Research Institute
OTHER
Henan Provincial People's Hospital
OTHER
Hunan Cancer Hospital
OTHER
Zhejiang Cancer Hospital
OTHER
First Affiliated Hospital of Wenzhou Medical University
OTHER
Ningbo No. 1 Hospital
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Women's Hospital School Of Medicine Zhejiang University
OTHER